10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says

Over the next six years, 10 drugs that are in the pre-registration phase and expected to launch this year are projected to reach blockbuster status.

GlobalData, a leading data and analytics company, pegged the 10 drugs to hit sales of $1 billion and more per year. The bulk of the treatments that are coming to market are in oncology and disorders of the central nervous system. While most of the medications are considered innovator drugs, that is the first drugs of its kind with a specific active ingredient, at least one is a biosimilar.